Background: Keratin 17 (K17) is regarded as a basal/myoepithelial cell keratin and is known to be inducible in activated keratinocytes. The high frequency of K17 expression in pancreaticobiliary nonmucinous adenocarcinoma or basal-like breast carcinoma has previously been described. However, its expression in gastric cancer (GC) is controversial.
Methods: We investigated the clinicopathological features and prognostic significance of 192 patients with GC by immunohistochemical staining of tissue microarrays. Analysis of epithelial markers including K17, K14, and K5/6, cell cycle-associated proteins p53, Ki-67, and 14-3-3 sigma, and mucinous phenotype markers including CD10, CDX2, MUC5AC, and MUC6 was performed.
Results: Cytoplasmic expression of K17 was observed in 95 (49.5%) of 192 patients with GC. K17 expression positively correlated with lymph node metastasis (P = 0.003) and advanced stages of the disease (P = 0.014). K17 expression was significantly correlated with 14-3-3 sigma expression (P < 0.001) and CD10 expression (P = 0.015). The overall survival rates of patients with K17-positive GC were significantly lower than those with negative K17 expression (50.5 vs. 71.1%, P = 0.004). Univariate analysis revealed that K17 expression confers a poor prognosis in patients with GC (P = 0.004), and it was also an independent prognostic factor in multivariate analysis (P = 0.049).
Conclusions: K17 expression is correlated with tumor progression in GC and may serve as a biomarker for poor prognosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1245/s10434-012-2437-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Validation of Keratin 17 as a tissue biomarker in the diagnosis of upper tract urothelial carcinoma.
Hum Pathol
November 2024
Department of Pathology, University of California Irvine Medical Center, 101 The City Dr. South, Orange, 92868, CA, USA. Electronic address:
Article Synopsis
- Upper tract urothelial carcinoma (UTUC) presents diagnostic and treatment challenges, highlighting the need for new biomarkers for tumor detection.
- * In a study of 139 UTUC cases, Keratin 17 (KRT17) showed significantly higher expression in malignant tumors compared to normal tissue, particularly in noninvasive and invasive forms.
- * The KRT17 marker demonstrated strong sensitivity (91%) and specificity (69%) for distinguishing benign from malignant tumors, suggesting its potential utility in future diagnostic practices.
The expression of keratin 17 and p27 predicts clinical outcomes in colorectal cancer.
APMIS
January 2025
Department of Pathology, Chung-Ang University Hospital, College of Medicine, Chung-Ang University, Seoul, South Korea.
Article Synopsis
- Keratin 17 (K17) overexpression is linked to worse prognosis in colorectal cancer, with high levels associated with aggressive tumor characteristics and lower patient survival rates.
- Low levels of p27 also correlate with larger tumors and poorer overall survival outcomes.
- The combined expression of K17 and p27 serves as a strong independent indicator of poor prognosis in colorectal cancer, highlighting their potential as clinical markers.
Acetylation of DnaJ facilitates the proliferation of BmNPV by affecting the transport of nucleocapsids.
Microb Pathog
December 2024
Institute of Biochemistry, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Zhejiang Province, Hangzhou, 310018, PR China; Zhejiang Provincial Key Laboratory of Silkworm Bioreactor and Biomedicine, Zhejiang Province, Hangzhou, 310018, PR China. Electronic address:
Article Synopsis
- DnaJ (Orf40) is a key protein in the Bombyx mori nucleopolyhedrovirus that is crucial for the budding of new virus particles and transporting nucleocapsids from the nucleus to the cytoplasm.
- Previous research showed that reducing DnaJ levels prevents nucleocapsids from leaving the nucleus, but how this process is regulated was not clear.
- Our study found that acetylation of a specific lysine residue (K17) in DnaJ enhances viral replication by improving nucleocapsid interaction with proteins and their transport within the cell, while deacetylation disrupts this process and reduces virus production.
Keratin 17 and A2ML1 are negative prognostic biomarkers in non-small cell lung cancer.
Pathol Res Pract
November 2024
Department of Pathology, Renaissance School of Medicine, Stony Brook, NY 11794, USA. Electronic address:
Although the overall prognosis for patients with non-small cell lung cancer (NSCLC) has improved over the past several decades, there are still survival differences that are not accurately defined by clinicopathological factors. Thus, there is an unmet clinical need to develop novel approaches to enhance prognostic accuracy for these patients. Keratin 17 (K17) is a negative prognostic biomarker in a wide range of cancer types, including pancreatic ductal adenocarcinoma, head and neck squamous cell carcinoma, and pulmonary adenocarcinoma (LUAD), but has yet to be investigated as a prognostic biomarker in primary lung squamous cell carcinoma (LSCC).
View Article and Find Full Text PDFInhibition of KPNA2 by ivermectin reduces E2F1 nuclear translocation to attenuate keratinocyte proliferation and ameliorate psoriasis-like lesions.
Int Immunopharmacol
December 2024
State Key Laboratory of Analytical Chemistry for Life Science & Jiangsu Key Laboratory of Molecular Medicine, Medical School, Nanjing University, Nanjing 210093, PR China. Electronic address:
Article Synopsis
- * Using ivermectin, which inhibits KPNA2, significantly improved psoriasis symptoms in mice by reducing redness, scaling, and thickness of the skin, alongside lower levels of KPNA2 and markers of skin cell growth.
- * The research also showed that reducing KPNA2 affected key signaling pathways in skin cells, suggesting it plays a crucial role in the development of psoriasis and could be a viable target for new treatments in the future.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!